Innate Pharma SA
LSE:0EVI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innate Pharma SA
LSE:0EVI
|
FR |
|
ADTRAN Holdings Inc
F:QH9
|
US |
Multiples-Based Value
The Multiples-Based Value for
Innate Pharma SA (0EVI) under the Base Case is 1.818 EUR.
Compared with the current market price of 1.544 EUR, the stock appears
Undervalued by 15% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.